Todos Medical Ltd. (TOMDF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2022 | 50.15 Million USD | 27.54% |
| 2021 | 39.32 Million USD | 131.06% |
| 2020 | 17.02 Million USD | 168.47% |
| 2019 | 6.33 Million USD | 348.02% |
| 2018 | 1.41 Million USD | -34.37% |
| 2017 | 2.15 Million USD | 118.28% |
| 2016 | 987.76 Thousand USD | 20.49% |
| 2015 | 819.79 Thousand USD | 14.44% |
| 2014 | 716.37 Thousand USD | 5.31% |
| 2013 | 680.24 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q3 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q1 | - USD | -100.0% |
| 2022 Q3 | 44.86 Million USD | 1.38% |
| 2022 Q2 | 44.25 Million USD | 13.82% |
| 2022 FY | 50.15 Million USD | 27.54% |
| 2022 Q1 | 38.87 Million USD | -1.14% |
| 2022 Q4 | 50.15 Million USD | 11.8% |
| 2021 FY | 39.32 Million USD | 131.06% |
| 2021 Q1 | 25.85 Million USD | 51.92% |
| 2021 Q4 | 39.32 Million USD | 42.18% |
| 2021 Q2 | 26.25 Million USD | 1.55% |
| 2021 Q3 | 27.66 Million USD | 5.34% |
| 2020 FY | 17.02 Million USD | 168.47% |
| 2020 Q1 | - USD | -100.0% |
| 2020 Q4 | 17.02 Million USD | 0.0% |
| 2019 FY | 6.33 Million USD | 348.02% |
| 2019 Q4 | 6.33 Billion USD | 0.0% |
| 2018 FY | 1.41 Million USD | -34.37% |
| 2018 Q4 | 14 Thousand USD | 0.0% |
| 2017 FY | 2.15 Million USD | 118.28% |
| 2017 Q4 | -8000.00 USD | 0.0% |
| 2016 FY | 987.76 Thousand USD | 20.49% |
| 2015 Q2 | 750.04 Thousand USD | 0.0% |
| 2015 Q4 | 819.79 Thousand USD | 0.0% |
| 2015 Q1 | 750.04 Thousand USD | 4.7% |
| 2015 Q3 | 819.79 Thousand USD | 9.3% |
| 2015 FY | 819.79 Thousand USD | 14.44% |
| 2014 Q3 | 716.37 Thousand USD | 0.0% |
| 2014 Q4 | 716.37 Thousand USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 FY | 716.37 Thousand USD | 5.31% |
| 2013 FY | 680.24 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Bio Medica Corporation | 3.6 Million USD | -1290.161% |
| Arrayit Corporation | 7.49 Million USD | -569.064% |
| Atlantic International Corp. | 3.82 Million USD | -1210.055% |
| Biocept, Inc. | 22.01 Million USD | -127.852% |
| Bioqual, Inc. | 18.93 Million USD | -164.849% |
| CardioGenics Holdings Inc | 1.79 Million USD | -2694.382% |
| DermTech, Inc. | 64.75 Million USD | 22.543% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 734.97 Million USD | 93.176% |
| HTG Molecular Diagnostics, Inc. | 12.38 Million USD | -304.951% |
| iMD Companies, Inc. | 1.67 Million USD | -2895.85% |
| IDenta Corp. | 1.01 Million USD | -4850.561% |
| Interpace Biosciences, Inc. | 28.15 Million USD | -78.133% |
| Integrative Health Technologies, Inc. | 297.94 Thousand USD | -16734.202% |
| InVitro International | 78.99 Thousand USD | -63397.911% |
| Lumos Diagnostics Holdings Limited | 19.72 Million USD | -154.23% |
| Many Bright Ideas Technologies Inc. | 129.29 Thousand USD | -38692.083% |
| Medical Imaging Corp. | 9.51 Million USD | -427.021% |
| NovelStem International Corp. | 4.2 Million USD | -1092.488% |
| Optigenex Inc. | 9.57 Million USD | -424.073% |
| PharmChem, Inc. | 558.64 Thousand USD | -8878.299% |
| Proteome Sciences plc | 18.48 Million USD | -171.279% |
| Response Genetics, Inc | 15.86 Million USD | -216.109% |
| Rennova Health, Inc. | 49.66 Million USD | -0.986% |
| RushNet, Inc. | 6.23 Million USD | -703.928% |
| ScreenPro Security Inc. | 1.6 Million USD | -3033.663% |
| Stella Diagnostics Inc. | 18 Million USD | -178.566% |
| StageZero Life Sciences Ltd. | 8.2 Million USD | -511.373% |